Privi Speciality Chemicals Limited (BOM:530117)
India · Delayed Price · Currency is INR 2,800.10
+51.15 (1.86%)
At close: Feb 12, 2026
BOM:530117 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 24,557 | 21,012 | 17,522 | 16,078 | 14,037 | 12,766 | |
Revenue Growth (YoY) | 24.53% | 19.91% | 8.98% | 14.54% | 9.96% | -3.59% |
Cost of Revenue | 14,346 | 13,001 | 11,612 | 11,281 | 9,466 | 7,658 |
Gross Profit | 10,211 | 8,011 | 5,910 | 4,797 | 4,571 | 5,107 |
Selling, General & Admin | 1,131 | 865.11 | 727.36 | 796.88 | 766.85 | 700.3 |
Other Operating Expenses | 3,092 | 2,609 | 1,930 | 2,135 | 1,866 | 2,331 |
Operating Expenses | 5,645 | 4,791 | 3,892 | 4,016 | 3,380 | 3,741 |
Operating Income | 4,565 | 3,219 | 2,018 | 780.79 | 1,192 | 1,366 |
Interest Expense | -862.76 | -878.83 | -979.39 | -678.13 | -241.13 | -214.1 |
Interest & Investment Income | 38.67 | 38.67 | 3.22 | 2.82 | 2.99 | 4.81 |
Currency Exchange Gain (Loss) | 122.57 | 122.57 | 188.28 | 182.08 | 295 | 185.67 |
Other Non Operating Income (Expenses) | 114.35 | 22.04 | 24.16 | 22.37 | 10 | 7.05 |
EBT Excluding Unusual Items | 3,978 | 2,524 | 1,254 | 309.94 | 1,259 | 1,349 |
Gain (Loss) on Sale of Investments | 11.31 | 11.31 | 25.45 | 6.18 | 0.03 | 1.86 |
Gain (Loss) on Sale of Assets | 4.53 | 4.53 | 19.32 | -5.94 | 0.07 | 0.03 |
Other Unusual Items | 5.49 | 5.49 | - | 0.26 | -163.26 | 0.17 |
Pretax Income | 4,000 | 2,545 | 1,299 | 310.43 | 1,328 | 1,582 |
Income Tax Expense | 1,134 | 697.73 | 344.8 | 97.65 | 353.74 | 413.22 |
Earnings From Continuing Operations | 2,866 | 1,848 | 954.3 | 212.78 | 973.8 | 1,169 |
Minority Interest in Earnings | 137.68 | 22.46 | -5.22 | 9.37 | - | - |
Net Income | 3,004 | 1,870 | 949.07 | 222.15 | 973.8 | 1,169 |
Net Income to Common | 3,004 | 1,870 | 949.07 | 222.15 | 973.8 | 1,169 |
Net Income Growth | 98.27% | 97.03% | 327.23% | -77.19% | -16.70% | -19.95% |
Shares Outstanding (Basic) | 39 | 39 | 39 | 39 | 39 | 39 |
Shares Outstanding (Diluted) | 39 | 39 | 39 | 39 | 39 | 39 |
Shares Change (YoY) | 0.39% | - | - | - | - | - |
EPS (Basic) | 76.89 | 47.87 | 24.30 | 5.69 | 24.93 | 29.93 |
EPS (Diluted) | 76.89 | 47.87 | 24.30 | 5.69 | 24.93 | 29.93 |
EPS Growth | 97.50% | 97.03% | 327.23% | -77.19% | -16.70% | -19.94% |
Free Cash Flow | - | -180.27 | 2,040 | -909.33 | -3,039 | -934.89 |
Free Cash Flow Per Share | - | -4.62 | 52.22 | -23.28 | -77.80 | -23.93 |
Dividend Per Share | - | 5.000 | 2.000 | - | 2.000 | 2.000 |
Dividend Growth | - | 150.00% | - | - | - | 33.33% |
Gross Margin | 41.58% | 38.13% | 33.73% | 29.84% | 32.57% | 40.01% |
Operating Margin | 18.59% | 15.32% | 11.52% | 4.86% | 8.49% | 10.70% |
Profit Margin | 12.23% | 8.90% | 5.42% | 1.38% | 6.94% | 9.16% |
Free Cash Flow Margin | - | -0.86% | 11.64% | -5.66% | -21.65% | -7.32% |
EBITDA | 5,873 | 4,463 | 3,175 | 1,787 | 1,903 | 2,044 |
EBITDA Margin | 23.91% | 21.24% | 18.12% | 11.11% | 13.56% | 16.01% |
D&A For EBITDA | 1,308 | 1,243 | 1,157 | 1,006 | 711.28 | 678.2 |
EBIT | 4,565 | 3,219 | 2,018 | 780.79 | 1,192 | 1,366 |
EBIT Margin | 18.59% | 15.32% | 11.52% | 4.86% | 8.49% | 10.70% |
Effective Tax Rate | 28.34% | 27.41% | 26.54% | 31.46% | 26.65% | 26.12% |
Revenue as Reported | 24,856 | 21,218 | 17,785 | 16,292 | 14,361 | 12,965 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.